ORIENT BIO Inc. (KRX: 002630)
South Korea flag South Korea · Delayed Price · Currency is KRW
420.00
-34.00 (-7.49%)
Nov 15, 2024, 3:30 PM KST

ORIENT BIO Income Statement

Millions KRW. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 2016 - 2012
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 2016 - 2012
Operating Revenue
59,09152,02037,21430,37325,625109,019
Upgrade
Other Revenue
-0-0---0-
Upgrade
Revenue
59,09152,02037,21430,37325,625109,019
Upgrade
Revenue Growth (YoY)
19.53%39.79%22.52%18.53%-76.50%3.78%
Upgrade
Cost of Revenue
37,84033,24730,93927,77323,399101,005
Upgrade
Gross Profit
21,25118,7736,2752,6002,2268,014
Upgrade
Selling, General & Admin
11,1209,35911,98810,00410,14014,884
Upgrade
Research & Development
1,9782,6451,406655.28-1,618
Upgrade
Other Operating Expenses
1,277922.06952.7970.93-278.68
Upgrade
Operating Expenses
24,12223,17221,43312,39210,14017,794
Upgrade
Operating Income
-2,870-4,399-15,158-9,791-7,914-9,780
Upgrade
Interest Expense
-558.39-559.69-664.06-3,441--2,832
Upgrade
Interest & Investment Income
736.24620.08388.3188.84-274.6
Upgrade
Currency Exchange Gain (Loss)
276.53-827.691,1531,233-25.79
Upgrade
Other Non Operating Income (Expenses)
3,971-1,8372,8501,134-5,210-5,078
Upgrade
EBT Excluding Unusual Items
1,555-7,003-11,431-10,676-13,125-17,390
Upgrade
Gain (Loss) on Sale of Investments
-3,238-3,601849.66--142.54
Upgrade
Gain (Loss) on Sale of Assets
40.862.275.54--610.9
Upgrade
Asset Writedown
-5,033-5,064-2,312---6,591
Upgrade
Other Unusual Items
--2.36-22.32-2,506--
Upgrade
Pretax Income
-6,675-15,668-12,910-13,182-13,125-23,228
Upgrade
Income Tax Expense
178.04-34.44-150.76--2,069
Upgrade
Earnings From Continuing Operations
-6,853-15,633-12,759-13,182-13,125-25,297
Upgrade
Earnings From Discontinued Operations
----16,992-3,086-
Upgrade
Net Income to Company
-6,853-15,633-12,759-30,174-16,211-25,297
Upgrade
Minority Interest in Earnings
-0.06-0.13763.2610,6682,3465,714
Upgrade
Net Income
-6,853-15,634-11,996-19,506-13,865-19,582
Upgrade
Net Income to Common
-6,853-15,634-11,996-19,506-13,865-19,582
Upgrade
Shares Outstanding (Basic)
119113103787270
Upgrade
Shares Outstanding (Diluted)
119113103787270
Upgrade
Shares Change (YoY)
8.36%9.70%32.48%8.49%2.09%10.20%
Upgrade
EPS (Basic)
-57.81-138.07-116.23-250.38-193.08-278.40
Upgrade
EPS (Diluted)
-57.81-138.07-116.23-251.46-193.08-278.40
Upgrade
Free Cash Flow
9,3308,483-4,647-27,620-4,953-10,391
Upgrade
Free Cash Flow Per Share
78.7074.92-45.03-354.53-68.98-147.74
Upgrade
Gross Margin
35.96%36.09%16.86%8.56%8.69%7.35%
Upgrade
Operating Margin
-4.86%-8.46%-40.73%-32.24%-30.89%-8.97%
Upgrade
Profit Margin
-11.60%-30.05%-32.24%-64.22%-54.11%-17.96%
Upgrade
Free Cash Flow Margin
15.79%16.31%-12.49%-90.93%-19.33%-9.53%
Upgrade
EBITDA
1,339292.75-10,240-1,714-618.01-3,115
Upgrade
EBITDA Margin
2.27%0.56%-27.52%-5.64%-2.41%-2.86%
Upgrade
D&A For EBITDA
4,2104,6914,9188,0787,2966,665
Upgrade
EBIT
-2,870-4,399-15,158-9,791-7,914-9,780
Upgrade
EBIT Margin
-4.86%-8.46%-40.73%-32.24%-30.89%-8.97%
Upgrade
Advertising Expenses
-167.82316.16277.61-447.88
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.